While the potential involvement of IL-1R in IL-1α’s therapeutic effects remains to be confirmed in vivo, our in vitro results suggest a complex mechanism of action that could shed light on why IL-RA stroke therapy has met with mixed success. This evidence concerns the gene IL1R1 and Stroke.